Catalyst Wire Dossier Catalyst Wire Dossier

TAFLUPROST OPHTHALMIC

TAFLUPROST · Prasco Laboratories
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TAFLUPROST OPHTHALMIC, covering 2012-02-10 to 2026-02-25. Get the full timeline:

Most recent: FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)

See pricing